Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium for mild-to-moderate Alzheimer's disease
jRCTs041180034Completed
- Sponsor
- Japan Society for the Promotion of Science
- Start
- Jul 2016
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Alzheimer's disease (AD) comparing Lithium carbonate with Placebo (2 arms). Primary endpoint: ADAS-cog total score change. Started Jul 2016; status: completed.
02
Drugs
lithium carbonate
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on jRCTs041180034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180034.